Seeking value primarily in developed markets worldwide

The Fund invests primarily in common and preferred stocks of United States and non-United States companies, including companies in emerging markets. Normally, the Fund invests the majority of its total assets in companies that pay dividends or otherwise seek to return capital to shareholders, such as by repurchasing their shares.

The Fund may invest up to 25% of its total assets in companies in emerging (less developed) markets, which may include investments through legal structures known as variable interest entities (“VIEs”). Under normal circumstances, the Fund will invest no more than 60% of its total assets in the United States and at least 40% of its total assets in a number of countries outside the United States. The Fund is not required to allocate its investments in any specific percentages in any particular countries.

Please see the Prospectus and Supplement for more information. Please contact [email protected] for a Fund Application.

Nav*
$11.56
Inception**
July 18, 2025
ISIN
IE000HM5ME21
Benchmark
MSCI ACWI
Minimum investment
$1,000,000
Total expense ratio
0.63%
*As of December 30, 2025
**Inception for USD Accumulation RDR Share Class
Download Fact Sheet Download Prospectus
Contact Us

Strategy overview

The portfolio managers discuss our Global Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Month end (as of November 30, 2025)
Table Header QTD YTD Since inception
Fund 2.5%0.0%9.6%
MSCI ACWI 2.3%0.0%8.9%
Table Header QTD YTD Since inception
Fund 2.5%0.0%9.6%
MSCI ACWI 2.3%0.0%8.9%

Portfolio (as of November 30, 2025)

Benchmark: MSCI ACWI
Asset Allocation
Table Header Fund
Stocks 98.8%
Cash 1.2%
Fund Characteristics
Table Header Fund Benchmark
Holdings 55 2517
Weighted avg. market cap (US $MM) $168,685 $843,594
Price/book value 2.0 3.6
FY2 price/earnings 13.0 18.7
Net assets $290,919,663.31 -
TOP 10 HOLDINGS
Security Country Weight*
Kering SA France 5.2%
Alstom SA France 3.3%
Alphabet, Inc. United States 3.1%
AstraZeneca PLC United Kingdom 3.0%
Renesas Electronics Corp. Japan 3.0%
Merck & Co., Inc. United States 3.0%
Infineon Technologies AG Germany 2.7%
Biogen, Inc. United States 2.6%
Samsung Electronics Co., Ltd. South Korea 2.6%
Genpact Ltd. United States 2.4%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator. Data is from the Investment Adviser’s accounting system and will differ from the Fund’s official net asset value for reasons including: differences in the accrual of certain expenses, income, and recognition of cash flows, and fund holidays.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Fund Benchmark
Information Technology 20.8% 27.3%
Financials 14.7% 17.1%
Health Care 14.4% 9.2%
Industrials 12.5% 10.5%
Consumer Discretionary 11.9% 10.2%
Communication Services 10.7% 9.0%
Consumer Staples 5.5% 5.2%
Materials 4.9% 3.5%
Utilities 1.3% 2.6%
Real Estate 1.0% 1.8%
Energy 1.0% 3.4%
TOP 10 COUNTRIES
Country Strategy Benchmark
United States 46.7% 64.7%
United Kingdom 14.9% 3.2%
France 9.5% 2.3%
Japan 8.3% 4.9%
Germany 5.6% 2.1%
Netherlands 4.7% 1.1%
South Korea 2.6% 1.3%
China 1.9% 3.1%
Sweden 1.7% 0.8%
Switzerland 1.4% 2.0%
Regional Allocation
  • North America 46.7%
  • Euro 20.5%
  • Europe - Other 18.0%
  • Pacific 8.3%
  • Emerging Asia 4.5%
  • Emerging Europe, Middle East, Africa 0.8%

Commentary (As of November 30, 2025)

Highlights

  • Global equity markets were broadly flat for November, but style performance diverged, with value stocks outperforming growth in certain regions.
  • Market trends in 2025 year-to-date point to a notable shift in investor sentiment and capital rotation toward non-US equity markets.
  • We are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations.

Portfolio Attribution

The Causeway Global Value UCITS Fund ("Fund") outperformed the Index during the month, due primarily to stock selection. On a gross return basis, Fund holdings in the pharmaceuticals & biotechnology, semiconductors & semi equipment, and software & services industry groups contributed to relative performance. Holdings in the technology hardware & equipment, consumer services, and media & entertainment industry groups offset some of the outperformance compared to the Index. The top contributor to return was diversified pharmaceutical company, Merck & Co., Inc. (United States). Other notable contributors included technology conglomerate, Alphabet, Inc. (United States), and global biotechnology company, Biogen, Inc. (United States). The largest detractor was electronic equipment manufacturer, Samsung Electronics Co., Ltd. (South Korea). Additional notable detractors included cruise ship operator, Carnival Corp. (United States), and multinational luxury conglomerate, Kering SA (France).

Investment Outlook

Market trends in 2025 year-to-date point to a notable shift in investor sentiment and capital rotation toward non-US equity markets. European fund inflows accelerated in the first half of the year, helping fuel the 12% appreciation of the euro versus the US dollar through the end of November. Year-to-date, US dollar weakness accounts for much of the outperformance of international markets. This strong developed international equity outperformance in US-dollar terms has likely renewed investor interest in undervalued European, UK, and Japanese equities. Strong developed international equity outperformance relative to the US market has likely renewed investor interest in undervalued European, UK, and Japanese equities. Strong developed international equity outperformance relative to the US market has likely renewed investor interest in undervalued European, UK, and Japanese equities.

The current rise of international value indices over growth provides a constructive backdrop for our value-oriented investment style. Among the leading non-US sectors in 2025, we see continued upside potential in financials, industrials, information technology, and consumer staples. Several of the portfolio’s lagging stocks this year appear well-positioned to outperform in 2026 as management teams execute on earnings and cash-flow improvements, inspiring market confidence.

The market commentary expresses the portfolio managers' views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and any portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. Any securities identified and described do not represent all of the securities purchased, sold or recommended for the Fund. Index returns assume reinvestment of dividends and capital gains, and assume no management, custody, transaction or other expenses. The reader should not assume that an investment in any securities identified was or will be profitable. MSCI has not approved, reviewed or produced this report, makes no express or implied warranties or representations and is not liable whatsoever for any data in the report. You may not redistribute the MSCI data or use it as a basis for other indices or investment products.

Documents

Fund information: